141 related articles for article (PubMed ID: 25841877)
1. Translational research for Parkinson׳s disease: The value of pre-clinical primate models.
Aron Badin R; Vadori M; Cozzi E; Hantraye P
Eur J Pharmacol; 2015 Jul; 759():118-26. PubMed ID: 25841877
[TBL] [Abstract][Full Text] [Related]
2. Why bother using non-human primate models of cognitive disorders in translational research?
Camus S; Ko WK; Pioli E; Bezard E
Neurobiol Learn Mem; 2015 Oct; 124():123-9. PubMed ID: 26135120
[TBL] [Abstract][Full Text] [Related]
3. Nonhuman primate models in translational regenerative medicine.
Daadi MM; Barberi T; Shi Q; Lanford RE
Stem Cells Dev; 2014 Dec; 23 Suppl 1(Suppl 1):83-7. PubMed ID: 25457970
[TBL] [Abstract][Full Text] [Related]
4. The translational value of non-human primates in preclinical research on infection and immunopathology.
't Hart BA; Bogers WM; Haanstra KG; Verreck FA; Kocken CH
Eur J Pharmacol; 2015 Jul; 759():69-83. PubMed ID: 25814254
[TBL] [Abstract][Full Text] [Related]
5. The safety, efficacy and regulatory triangle in drug development: Impact for animal models and the use of animals.
van Meer PJ; Graham ML; Schuurman HJ
Eur J Pharmacol; 2015 Jul; 759():3-13. PubMed ID: 25818943
[TBL] [Abstract][Full Text] [Related]
6. Subthalamic GAD gene transfer in Parkinson disease patients who are candidates for deep brain stimulation.
During MJ; Kaplitt MG; Stern MB; Eidelberg D
Hum Gene Ther; 2001 Aug; 12(12):1589-91. PubMed ID: 11529246
[TBL] [Abstract][Full Text] [Related]
7. Validity of animal models of type 1 diabetes, and strategies to enhance their utility in translational research.
Graham ML; Schuurman HJ
Eur J Pharmacol; 2015 Jul; 759():221-30. PubMed ID: 25814249
[TBL] [Abstract][Full Text] [Related]
8. Regulatory acceptance of animal models of disease to support clinical trials of medicines and advanced therapy medicinal products.
Cavagnaro J; Silva Lima B
Eur J Pharmacol; 2015 Jul; 759():51-62. PubMed ID: 25814257
[TBL] [Abstract][Full Text] [Related]
9. Oestrogen and nigrostriatal dopaminergic neurodegeneration: animal models and clinical reports of Parkinson's disease.
Liu B; Dluzen DE
Clin Exp Pharmacol Physiol; 2007 Jul; 34(7):555-65. PubMed ID: 17581209
[TBL] [Abstract][Full Text] [Related]
10. Experimental colitis models: Insights into the pathogenesis of inflammatory bowel disease and translational issues.
Valatas V; Bamias G; Kolios G
Eur J Pharmacol; 2015 Jul; 759():253-64. PubMed ID: 25814256
[TBL] [Abstract][Full Text] [Related]
11. Rodent models for human diseases.
Vandamme TF
Eur J Pharmacol; 2015 Jul; 759():84-9. PubMed ID: 25823811
[TBL] [Abstract][Full Text] [Related]
12. Using viral-mediated gene delivery to model Parkinson's disease: do nonhuman primate investigations expand our understanding?
Fiandaca MS; Federoff HJ
Exp Neurol; 2014 Jun; 256():117-25. PubMed ID: 23524194
[TBL] [Abstract][Full Text] [Related]
13. Mouse models rarely mimic the transcriptome of human neurodegenerative diseases: A systematic bioinformatics-based critique of preclinical models.
Burns TC; Li MD; Mehta S; Awad AJ; Morgan AA
Eur J Pharmacol; 2015 Jul; 759():101-17. PubMed ID: 25814260
[TBL] [Abstract][Full Text] [Related]
14. Animal models of human disease: challenges in enabling translation.
McGonigle P; Ruggeri B
Biochem Pharmacol; 2014 Jan; 87(1):162-71. PubMed ID: 23954708
[TBL] [Abstract][Full Text] [Related]
15. Reconsideration of animal models of schizophrenia and other psychiatric disorders with evolutionary perspective.
Lee YA; Goto Y
Med Hypotheses; 2013 Dec; 81(6):1120-6. PubMed ID: 24199948
[TBL] [Abstract][Full Text] [Related]
16. The Miniature Swine as a Model in Experimental and Translational Medicine.
Stricker-Krongrad A; Shoemake CR; Bouchard GF
Toxicol Pathol; 2016 Jun; 44(4):612-23. PubMed ID: 27073085
[TBL] [Abstract][Full Text] [Related]
17. Alzheimer's disease drug development: translational neuroscience strategies.
Cummings JL; Banks SJ; Gary RK; Kinney JW; Lombardo JM; Walsh RR; Zhong K
CNS Spectr; 2013 Jun; 18(3):128-38. PubMed ID: 23472637
[TBL] [Abstract][Full Text] [Related]
18. Key factors determining the efficacy of gene therapy for continuous DOPA delivery in the Parkinsonian brain.
Cederfjäll E; Sahin G; Kirik D
Neurobiol Dis; 2012 Nov; 48(2):222-7. PubMed ID: 22048069
[TBL] [Abstract][Full Text] [Related]
19. A Critical Evaluation of the Methodological Obstacles to Translating Cell-Based Research Into an Effective Treatment for People With Parkinson's Disease.
Polgar S; Karimi L; Buultjens M; Morris ME
Neurorehabil Neural Repair; 2016 Oct; 30(9):845-53. PubMed ID: 26944320
[TBL] [Abstract][Full Text] [Related]
20. Gene therapy for Parkinson's disease: from non-human primates to humans.
Fiandaca MS; Bankiewicz KS
Curr Opin Mol Ther; 2010 Oct; 12(5):519-29. PubMed ID: 20886383
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
